We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pivotal Device Trial Guidance Said to Omit Key Information
Pivotal Device Trial Guidance Said to Omit Key Information
December 7, 2011
Besides lacking key information on confidentiality, a draft guidance seems to imply the FDA prefers randomized studies over other trial designs for pivotal studies of devices pursuing premarket approval and poses impossible barriers for trial manager, according to comments on the document.